Wilprafen solutab
Wilprafen solutab Uses, Dosage, Side Effects, Food Interaction and all others data.
A macrolide antibiotic from Streptomyces narbonensis. The drug has antimicrobial activity against a wide spectrum of pathogens.
Wilprafen solutab is a macrolide antibiotic from Streptomyces narbonensis. The drug has antimicrobial activity against a wide spectrum of pathogens.
| Trade Name | Wilprafen solutab |
| Generic | Josamycin |
| Josamycin Other Names | Josamicina, Josamycin, Josamycine, Josamycinum, Kitasamycin A3, Leucomycin A3 |
| Type | |
| Formula | C42H69NO15 |
| Weight | Average: 827.995 Monoisotopic: 827.466720543 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Russia |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Wilprafen solutab is a macrolide antibiotic used for the treatment of various susceptible bacterial infections.
For the treatment of bacterial infections.
Wilprafen solutab is also used to associated treatment for these conditions: Bacterial Infections, Biliary tract infection, Breast Infection, Dental and oral soft tissue infections, Genital infection, Respiratory Tract Infections (RTI), Soft Tissues Infections, Ear, nose, and throat infections
How Wilprafen solutab works
The mechanism of action of macrolides such as Wilprafen solutab is via inhibition of bacterial protein biosynthesis by binding reversibly to the subunit 50S of the bacterial ribosome, thereby inhibiting translocation of peptidyl tRNA. This action is mainly bacteriostatic, but can also be bactericidal in high concentrations. Macrolides tend to accumulate within leukocytes, and are therefore actually transported into the site of infection.
Innovators Monograph
You find simplified version here Wilprafen solutab
